NCT01391962 2026-02-02
Sunitinib or Cediranib for Alveolar Soft Part Sarcoma
National Institutes of Health Clinical Center (CC)
Phase 2 Completed
Clinical Trials
13 trialsNCT05340673 2026-01-28
Comparing Supplemental Topical Agents for the Treatment of Acute Radiation Dermatitis in Patients With Breast Cancer
City of Hope Medical Center
Phase 1 Active not recruiting
NCT04865731 2025-08-06
Dermaprazole Cream for Radiation Dermatitis in Head and Neck Cancer
The University of Texas Health Science Center at San Antonio
Phase 2 Completed
NCT03596073 2025-05-07
Topical Calcipotriene Treatment for Breast Cancer Immunoprevention
Massachusetts General Hospital
Phase 1 Terminated
NCT04329221 2025-05-07
Immunotherapy Before Transplantation for Skin Cancer Prevention in Organ Transplant Recipients
Massachusetts General Hospital
Phase 2 Withdrawn
NCT04642287 2025-05-07
Immunotherapy After Transplantation for Skin Cancer Prevention in Organ Transplant Recipients
Massachusetts General Hospital
Phase 2 Withdrawn
NCT05553392 2024-09-04
StrataXRT Versus Aquaphor for the Prevention and Management of Radiation Dermatitis
Stratpharma AG
Phase NA Terminated
NCT05073172 2024-05-06
StrataXRT for the Prevention and Treatment of Radiation Dermatitis in Breast Cancer or Head and Neck Cancer Patients
OHSU Knight Cancer Institute
Phase NA Withdrawn
NCT03279328 2019-06-25
Evaluating Skin Appearance Following 5-Flourouracil Cream for Treatment of Actinic Keratosis and the Effects of Topical Agents
University of Arizona
Phase 4 Completed
NCT02373722 2018-07-03
Website Application Based Education and Text Messaging in Improving Skin Wound Care in Patients Undergoing Mohs Surgery
Wake Forest University Health Sciences
Phase NA Completed
NCT02534129 2017-10-06
Topical Use of Difinsa53â„¢ to Prevent Radiation Dermatitis
ProTechSure Scientific, Inc.
Phase 1/2 Terminated
NCT02019355 2016-05-19
AK
Washington University School of Medicine
Phase EARLY_PHASE1 Completed
NCT00786994 2015-09-14
The Efficacy and Tolerability of Oleogel-S-10 in Patients With Actinic Keratoses
Amryt Pharma
Phase 2 Completed